The 5th International Conference on Biology and Bioengineering Innovations (ICBBI 2026), organized by iConf.com, invites researchers, industry leaders, and academics to submit pioneering research and case studies. Building on the success of ICBBI 2024 at Stanford University, this edition will take place October 20–23, 2026, in Boston, Massachusetts, USA, a global epicenter for biotechnology and biomedical innovation. The conference will spotlight breakthroughs in synthetic biology, biomedical engineering, and sustainable bioprocessing to address global health and environmental challenges.
Why Submit to ICBBI 2026 via iConf.com?
High-Impact Publication
Accepted papers will be published in Scopus and Web of Science-indexed proceedings, ensuring global visibility and academic credibility.
Exceptional contributions may qualify for fast-tracking to leading journals like Nature Biotechnology (IF: 54.9) or Cell Systems (IF: 10.0).
Rigorous yet Efficient Review
Submission Deadline: August 15, 2026 (early-bird registration discounts available).
Acceptance Notification: Within 21 days of submission.
Complimentary language editing and technical review support via iConf.com’s partner network.
Conference Themes
ICBBI 2026 bridges molecular biology with engineering innovation to tackle planetary-scale issues. Submissions are encouraged in:
Synthetic Biology & Genetic Engineering: CRISPR-Cas advancements, metabolic pathway design, microbial consortia optimization.
Biomedical Engineering: Tissue engineering, smart biomaterials, wearable biosensors, neural interface systems.
Sustainable Bioprocessing: Algae-based biofuels, waste-to-energy systems, circular bioeconomy frameworks.
AI-Driven Biology: Machine learning for drug discovery, predictive modeling of cellular dynamics, bioinformatics tool development.
Global Health Solutions: Rapid vaccine platforms, point-of-care diagnostics, antimicrobial resistance mitigation.
Environmental Biotechnology: Bioremediation strategies, enzymatic plastic degradation, carbon capture via bio-systems.
Submission Guidelines
Format: Follow the Elsevier BIO template (downloadable at iConf.com/icbbi-2026).
Originality: Submissions must be novel and pass plagiarism checks (≤15% similarity via iThenticate).
Submission Portal: Submit abstracts (300 words) or full papers (10–15 pages) via
https://www.iconf.com/submit-bio-2026.
Key Opportunities for Participants
Present Your Work: Choose from oral presentations, interactive poster sessions, or virtual participation.
Industry-Academia Synergy: Engage with keynote speakers like Dr. Jennifer Doudna (UC Berkeley, CRISPR pioneer) and Prof. Robert Langer (MIT, biomedical innovator), alongside experts from Moderna, Genentech, and Illumina.
Technical Workshops: Attend sessions such as “Scaling Synthetic Biology for Industrial Applications” or “Ethics in Gene Editing Technologies.”
Why Attend ICBBI 2026?
Networking: Connect with leading institutions (e.g., Harvard, ETH Zurich) and industry giants (e.g., Thermo Fisher, Ginkgo Bioworks).
Tech Expo: Explore innovations in lab automation, bioreactor systems, and AI-powered bioinformatics tools.
Policy & Ethics: Participate in panels on FDA regulatory pathways, biosecurity standards, and equitable access to biotech solutions.
Submit Now!
Secure your participation by submitting abstracts or full papers by August 15, 2026. For details, visit
